Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery (2014)
- Authors:
- Whellan, David J.
- Tricoci, Pierluigi
- Chen, Edmond
- Huang, Zhen
- Leibowitz, D.
- Vranckx, Pascal
- Marhefka, Gregory
- Held, Claes
- Nicolau, Jose C.
- Storey, Robert
- Ruzyllo, Witold
- Huber, Kurt
- Sinnaeve, Peter
- Weiss, Teddy
- Dery, Jean-Pierre
- Moliterno, David
- de Werf, Frans Van
- Aylward, Philip E.
- White, Harvey
- Armstrong, Paul W.
- Wallentin, Lars
- Strony, John
- Harrington, Robert A.
- Mahaffey, Keneth W.
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: HIPERCOLESTEROLEMIA; DOENÇAS CARDIOVASCULARES
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the American College of Cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 63, n. 11, p. 1048-1057, 2014
-
ABNT
WHELLAN, David J. et al. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery. Journal of the American College of Cardiology, v. 63, n. 11, p. 1048-1057, 2014Tradução . . Acesso em: 23 jan. 2026. -
APA
Whellan, D. J., Tricoci, P., Chen, E., Huang, Z., Leibowitz, D., Vranckx, P., et al. (2014). Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery. Journal of the American College of Cardiology, 63( 11), 1048-1057. -
NLM
Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, Marhefka G, Held C, Nicolau JC, Storey R, Ruzyllo W, Huber K, Sinnaeve P, Weiss T, Dery J-P, Moliterno D, de Werf FV, Aylward PE, White H, Armstrong PW, Wallentin L, Strony J, Harrington RA, Mahaffey KW. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery. Journal of the American College of Cardiology. 2014 ; 63( 11): 1048-1057.[citado 2026 jan. 23 ] -
Vancouver
Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, Marhefka G, Held C, Nicolau JC, Storey R, Ruzyllo W, Huber K, Sinnaeve P, Weiss T, Dery J-P, Moliterno D, de Werf FV, Aylward PE, White H, Armstrong PW, Wallentin L, Strony J, Harrington RA, Mahaffey KW. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery. Journal of the American College of Cardiology. 2014 ; 63( 11): 1048-1057.[citado 2026 jan. 23 ] - P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes
- Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction
- Doença arterial coronariana aguda
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
- Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
